These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1672698)
21. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade. McDevitt DG; Brown HC; Carruthers SG; Shanks RG Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753 [TBL] [Abstract][Full Text] [Related]
22. Propranolol does not alter cerebral blood flow and functions in cirrhotic patients without previous hepatic encephalopathy. Calès P; Pierre-Nicolas M; Guell A; Mauroux JL; Franco-Sempe A; Vinel JP; Geraud G; Pascal JP Hepatology; 1989 Mar; 9(3):439-42. PubMed ID: 2920999 [TBL] [Abstract][Full Text] [Related]
23. Cardio-protection afforded by β-blockade is maintained during resistance exercise. Conviser JM; Ng AV; Rockey SS; Thomas DP J Sci Med Sport; 2017 Feb; 20(2):196-201. PubMed ID: 27012728 [TBL] [Abstract][Full Text] [Related]
24. Beta blocker effects on heart rate during sleep: a placebo-controlled polysomnographic study with normotensive males. Rosen RC; Kostis JB; Seltzer LG; Taska LS; Holzer BC Sleep; 1991 Feb; 14(1):43-7. PubMed ID: 1687425 [TBL] [Abstract][Full Text] [Related]
25. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol. Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208 [TBL] [Abstract][Full Text] [Related]
26. Effect of acute and prolonged treatment with propranolol on cerebral blood flow and cerebral oxygen metabolism in healthy volunteers. Madsen PL; Vorstrup S; Schmidt JF; Paulson OB Eur J Clin Pharmacol; 1990; 39(3):295-7. PubMed ID: 2257870 [TBL] [Abstract][Full Text] [Related]
27. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects. Wójcicki J; Jaroszynska M; Droździk M; Pawlik A; Gawrońska-Szklarz B; Sterna R Biopharm Drug Dispos; 2003 Jul; 24(5):211-8. PubMed ID: 12784321 [TBL] [Abstract][Full Text] [Related]
28. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs. Bowden CR; Marchione CS J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694 [TBL] [Abstract][Full Text] [Related]
29. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects. Kerr D; MacDonald IA; Heller SR; Tattersall RB Br J Clin Pharmacol; 1990 Jun; 29(6):685-93. PubMed ID: 1974143 [TBL] [Abstract][Full Text] [Related]
30. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group. Conn HO; Grace ND; Bosch J; Groszmann RJ; Rodés J; Wright SC; Matloff DS; Garcia-Tsao G; Fisher RL; Navasa M Hepatology; 1991 May; 13(5):902-12. PubMed ID: 2029994 [TBL] [Abstract][Full Text] [Related]
31. Cardiovascular effects of beta-adrenoreceptor blocking agents after intracerebroventricular administration in conscious normotensive cats. Day MD; Roach AG Clin Exp Pharmacol Physiol; 1974; 1(4):333-9. PubMed ID: 4156505 [No Abstract] [Full Text] [Related]
32. Effect of intravenous infusion of a beta-adrenergic blocking agent on the haemodynamic changes in human masseter muscle induced by cold-pressor stimulation. Maekawa K; Kuboki T; Miyawaki T; Shimada M; Yamashita A; Clark GT Arch Oral Biol; 1999 Jun; 44(6):475-83. PubMed ID: 10401525 [TBL] [Abstract][Full Text] [Related]
33. Effect of propranolol on local cerebral blood flow under normocapnic and hypercapnic conditions. Dahlgren N; Ingvar M; Siesjö BK J Cereb Blood Flow Metab; 1981; 1(4):429-36. PubMed ID: 6799531 [TBL] [Abstract][Full Text] [Related]
34. Comparison of atenolol and propranolol during insulin-induced hypoglycaemia. Deacon SP; Barnett D Br Med J; 1976 Jul; 2(6030):272-3. PubMed ID: 8184 [TBL] [Abstract][Full Text] [Related]
35. Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol. Aramaki T; Sekiyama T; Katsuta Y; Kurokawa H; Komeichi H; Tsutsui H; Terada H; Ohsuga M; Satomura K; Okumura H J Hepatol; 1992 May; 15(1-2):48-53. PubMed ID: 1354676 [TBL] [Abstract][Full Text] [Related]
36. Weakness of mucosal barrier in portal hypertensive gastropathy of alcoholic cirrhosis. Effects of propranolol and enprostil. Payen JL; Cales P; Pienkowski P; Sozzani P; Kervran A; Frexinos J; Pascal JP J Hepatol; 1995 Dec; 23(6):689-96. PubMed ID: 8750168 [TBL] [Abstract][Full Text] [Related]
37. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men. Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847 [TBL] [Abstract][Full Text] [Related]
38. The Effects of Oral Atenolol or Enalapril Premedication on Blood Loss and Hypotensive Anesthesia in Orthognathic Surgery. Kim NY; Yoo YC; Chun DH; Lee HM; Jung YS; Bai SJ Yonsei Med J; 2015 Jul; 56(4):1114-21. PubMed ID: 26069137 [TBL] [Abstract][Full Text] [Related]
39. Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure. Pandhi P; Sharma PL Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):297-300. PubMed ID: 2887519 [TBL] [Abstract][Full Text] [Related]
40. Beta-adrenoceptor blockade and CNS-related subjective symptoms: a randomized, double-blind, placebo-controlled comparison of metoprolol CR/ZOK, atenolol and propranolol LA in healthy subjects. Dimenäs E; Kerr D; Macdonald I J Clin Pharmacol; 1990 Feb; 30(S2):S103-7. PubMed ID: 1968912 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]